Cho Young-Jae, Lee Sang Min, Yoo Chul-Gyu, Kim Young Whan, Han Sung Koo, Shim Young-Soo, Yim Jae-Joon
Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine and Lung Institute, Seoul National University College of Medicine, Seoul, Korea.
Respirology. 2007 May;12(3):401-5. doi: 10.1111/j.1440-1843.2007.01069.x.
Patients with liver cirrhosis are likely to be susceptible to tuberculosis (TB) because of immune system dysfunction. The aim of this study was to elucidate the clinical characteristics and treatment responses in TB patients with cirrhosis.
Cases were patients with TB detected during their follow up for liver cirrhosis over a 4-year period. Controls were randomly selected patients with TB but no liver disease, matched to cases by age and gender in a 3:1 ratio.
Thirty-six cases and 108 controls were enrolled. Extrapulmonary TB was more common in cases than controls (31% vs 12%, P = 0.02). Clinical and radiographic manifestations and response to treatment did not differ between the two groups. The frequency of hepatotoxicity was higher in the cases than in the controls who were treated with a regimen containing rifampicin and isoniazid, although the difference was not statistically significant (27% vs 10%, P = 0.079).
TB patients with liver cirrhosis show extrapulmonary involvement more frequently. Patients with pulmonary TB and cirrhosis usually respond well to anti-TB treatment although appear to present more frequently with treatment-related hepatotoxicity.
肝硬化患者由于免疫系统功能障碍,可能易患结核病(TB)。本研究旨在阐明肝硬化合并结核病患者的临床特征及治疗反应。
研究对象为在4年期间肝硬化随访过程中检测出结核病的患者。对照组为随机选取的无肝脏疾病的结核病患者,按年龄和性别以3:1的比例与病例组匹配。
共纳入36例病例和108例对照。肺外结核在病例组中比对照组更常见(31%对12%,P = 0.02)。两组的临床和影像学表现及治疗反应无差异。在接受含利福平及异烟肼方案治疗的患者中,病例组肝毒性的发生率高于对照组,尽管差异无统计学意义(27%对10%,P = 0.079)。
肝硬化合并结核病患者肺外受累更为常见。肺结核合并肝硬化患者通常对抗结核治疗反应良好,尽管似乎更常出现与治疗相关的肝毒性。